Stock AUROPHARMA AUROBINDO PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

News Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Delayed NSE India S.E.
Other stock markets
 03:06:14 2024-04-26 am EDT 		5-day change 1st Jan Change
1,132 INR +2.58% Intraday chart for Aurobindo Pharma +4.31% +4.60%
Apr. 07 Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President ­ R&D (Specialty Drug Delivery) CI
Apr. 02 Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President ­ R&D (Specialty Drug Delivery)
CI
Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India
MT
Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024
CI
Indian shares set to track Asian peers higher, eye on Fed meet
RE
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray
MT
Aurobindo Pharma Limited Receives Final Approval from the US Food & Drug Administration
CI
Aurobindo Pharma Arm Restarts Distribution of Aseptic Products from Unit III
MT
APL Healthcare Limited Subsidiary of Aurobindo Pharma Limited Announces Unit Inspection Team of World Health Organization Conducts an Inspection at the Unit IV
CI
Aurobindo Pharma Limited Appoints N. Ravikiran as Chief Business Officer
CI
Aurobindo Pharma Limited Receives USFDA Approval for Fingolimod Capsules, 0.5 Mg
CI
Indian shares set to rise on strong domestic growth, in-line US inflation data
RE
US FDA Completes Inspection of Aurobindo Pharma's Injectibles Unit
MT
Ex-dividend day for interim dividend
FA
US FDA Clears Aurobindo Pharma Arm's Manufacturing Unit in Telangana, India
MT
INDIA STOCKS-Auto stocks drive Indian shares higher
RE
Aurobindo Pharma Limited Receives USFDA Approval for Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg
CI
Aurobindo Pharma Clocks Gains in Fiscal Q3 Consolidated Net Profit
MT
INDIA STOCKS-Energy shares drag India's blue-chip stocks; small, mid-caps slide
RE
Transcript : Aurobindo Pharma Limited, Q3 2024 Earnings Call, Feb 12, 2024
Aurobindo Pharma Limited Approves the Resignation of Dr.(Mrs.) Avnit Bimal Singh as an Independent Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUROPHARMA Stock
  4. News Aurobindo Pharma